CTOs on the Move

Alkeus Pharmaceuticals, Inc.

www.alkeuspharma.com

 
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

sportsubarusouth

Visit our New Subaru Superstore in Orlando, FL. Conveniently located 1 mile south of the Turnpike on Orange Blossom Trail. View our HUGE selection of New Subaru models in stock. Genuine Subaru Parts, Accessories and Service by Factory Trained Technicians.

Soft Point

Soft Point is a Holbrook, NY-based company in the Business Services sector.

Ham

Ham is a Littleton, CO-based company in the Business Services sector.